검색결과 : 51건
| No. | Article |
|---|---|
| 1 |
Dynamic regulation of T-FH selection during the germinal centre reaction Merkenschlager J, Finkin S, Ramos V, Kraft J, Cipolla M, Nowosad CR, Hartweger H, Zhang WZ, Olinares PDB, Gazumyan A, Oliveira TY, Chait BT, Nussenzweig MC Nature, 591(7850), 458, 2021 |
| 2 |
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants Wang ZJ, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, Schaefer-Babajew D, Cipolla M, Gaebler C, Lieberman JA, Oliveira TY, Yang Z, Abernathy ME, Huey-Tubman KE, Hurley A, Turroja M, West KA, Gordon K, Millard KG, Ramos V, Da Silva J, Xu JL, Colbert RA, Patel R, Dizon J, Unson-O'Brien C, Shimeliovich I, Gazumyan A, Caskey M, Bjorkman PJ, Casellas R, Hatziioannou T, Bieniasz PD, Nussenzweig MC Nature, 592(7855), 616, 2021 |
| 3 |
Evolution of antibody immunity to SARS-CoV-2 Gaebler C, Wang ZJ, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, Hagglof T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O'Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RE, Hatziioannou T, Bjorkman PJ, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC Nature, 591(7851), 639, 2021 |
| 4 |
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice Cohen AA, Gnanapragasam PNP, Lee YE, Hoffman PR, Ou SS, Kakutani LM, Keeffe JR, Wu HJ, Howarth M, West AP, Barnes CO, Nussenzweig MC, Bjorkman PJ Science, 371(6530), 735, 2021 |
| 5 |
All eyes on the hurdle race for a SARS-CoV-2 vaccine Gaebler C, Nussenzweig MC Nature, 586(7830), 2020 |
| 6 |
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies Barnes CO, Jette CA, Abernathy ME, Dam KMA, Esswein SR, Gristick HB, Malyutin AG, Sharaf NG, Huey-Tubman KE, Lee YE, Robbiani DF, Nussenzweig MC, West AP, Bjorkman PJ Nature, 588(7839), 682, 2020 |
| 7 |
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies Barnes CO, Jette CA, Abernathy ME, Dam KMA, Esswein SR, Gristick HB, Malyutin AG, Sharaf NG, Huey-Tubman KE, Lee YE, Robbiani DF, Nussenzweig MC, West AP, Bjorkman PJ Nature, 588(7839), 682, 2020 |
| 8 |
Convergent antibody responses to SARS-CoV-2 in convalescent individuals Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang ZJ, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, Hagglof T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, Millard KG, Kost RG, Cipolla M, Gordon K, Bianchini F, Chen ST, Ramos V, Patel R, Dizon J, Shimeliovich I, Mendoza P, Hartweger H, Nogueira L, Pack M, Horowitz J, Schmidt F, Weisblum Y, Michailidis E, Ashbrook AW, Waltari E, Pak JE, Huey-Tubman KE, Koranda N, Hoffman PR, West AP, Rice CM, Hatziioannou T, Bjorkman PJ, Bieniasz PD, Caskey M, Nussenzweig MC Nature, 584(7821), 437, 2020 |
| 9 |
All eyes on the hurdle race for a SARS-CoV-2 vaccine Gaebler C, Nussenzweig MC Nature, 586(7830), 2020 |
| 10 |
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies Barnes CO, Jette CA, Abernathy ME, Dam KMA, Esswein SR, Gristick HB, Malyutin AG, Sharaf NG, Huey-Tubman KE, Lee YE, Robbiani DF, Nussenzweig MC, West AP, Bjorkman PJ Nature, 588(7839), 682, 2020 |